Search
for
Sort by
Research 181–210 of 315
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Nonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses
- Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Frontal fibrosing alopecia: A review of disease pathogenesis
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Myeloma, Paraproteinemias, and the Skin
- Amyloid-Associated Alopecia: A Reappraisal Including Its Pathophysiology
- Keratinic amyloid deposition in canine hair follicle tumors
- Quoi de neuf en recherche dermatologique ?
- The JAK/STAT signaling pathway: from bench to clinic
- Pathological sequelae of long-haul COVID
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Hair follicle immune privilege and its collapse in alopecia areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases
- Significance of stress keratin expression in normal and diseased epithelia
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis